G Medical Innovations Holdings Ltd (GMVDF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerG Medical Innovations Holdings Ltd (GMVDF) trades at $0.0001. G Medical Innovations Holdings Ltd is an early-stage healthcare company focused on developing and marketing mobile health and telemedicine solutions. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for GMVDF: GMVDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
G Medical Innovations Holdings Ltd (GMVDF) Healthcare & Pipeline Overview
G Medical Innovations Holdings Ltd, based in Israel, develops and markets mobile health and telemedicine solutions, including the Prizma multi-sensor device and the Extended Holter Patch System. The company focuses on continuous vital signs monitoring and ECG data capture, operating within the competitive medical devices sector.
What Is the Investment Thesis for GMVDF?
G Medical Innovations Holdings Ltd presents a compelling, albeit high-risk, investment opportunity within the burgeoning mobile health and telemedicine market. The company's Prizma and Extended Holter Patch System address the increasing need for remote patient monitoring and continuous health data capture. However, with a market capitalization of $0.00B and negative free cash flow of $-0.00B, the company's financial stability is a significant concern. A beta of 1523.14 indicates extreme volatility relative to the market. Growth hinges on successful commercialization of its products and expansion of its monitoring services. Investors should carefully weigh the potential for growth in the telemedicine sector against the company's current financial challenges and OTC market risks. The company's gross margin stands at 17.7%.
Based on FMP financials and quantitative analysis
GMVDF Key Highlights
G Medical Innovations Holdings Ltd operates in the rapidly growing mobile health and telemedicine market.
- The company's Prizma device offers multi-sensor vital signs monitoring, catering to proactive health management.
- The Extended Holter Patch System provides extended electrocardiography (ECG) data capture for cardiac monitoring.
- The company's gross margin is 17.7%.
- G Medical Innovations Holdings Ltd has a beta of 1523.14, indicating very high volatility.
Who Are GMVDF's Competitors?
GMVDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BJDX Bluejay Diagnostics, Inc. | $0.84 | -1.12% | 30 5-pillar | |
| NVNO enVVeno Medical Corporation | $8.10 | +0.75% | $5.63M | 30 5-pillar |
| BDMD Baird Medical Investment Holdings Limited | $0.75 | +0.91% | $31.7M | — |
| SNWV SANUWAVE Health, Inc. | $4.82 | +4.33% | $41.5M | 36 5-pillar |
| SRTS Sensus Healthcare, Inc. | $2.98 | +1.02% | $49.1M | 31 5-pillar |
| HYPD Hyperion DeFi, Inc. | $3.73 | +1.91% | $56.5M | 36 5-pillar |
| LNSR LENSAR, Inc. | $6.75 | +2.74% | $82.9M | 45 5-pillar |
| APYX Apyx Medical Corporation | $2.55 | +2.00% | $107M | 33 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GMVDF's Key Strengths?
Innovative mobile health and telemedicine solutions.
- Integrated platform combining devices and monitoring services.
- Focus on continuous vital signs monitoring.
- Proprietary technology in the Prizma device.
What Are GMVDF's Weaknesses?
Early commercial stage company with limited market presence.
- Negative free cash flow and limited financial resources.
- High beta indicating significant stock volatility.
- Reliance on OTC market for trading.
What Are the Key Risks for GMVDF?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the medical device and telehealth industries.
- Regulatory hurdles and reimbursement challenges.
- Limited financial resources and negative free cash flow.
- High stock volatility due to OTC market trading.
- Technological obsolescence.
What Are GMVDF's Competitive Advantages?
- Proprietary technology in multi-sensor vital signs monitoring (Prizma).
- Integrated solutions combining devices, monitoring services, and accessories.
- Focus on mobile health and telemedicine solutions.
- Established presence in the Israeli healthcare market.
What Does GMVDF Do?
G Medical Innovations Holdings Ltd, established in 2014 and headquartered in Rehovot, Israel, is an early commercial stage healthcare company specializing in the development of next-generation mobile health and telemedicine solutions. The company's core offerings include the Prizma system, a multi-sensor device designed to capture vital signs and generate health trend reports, enabling proactive health management. Another key product is the Extended Holter Patch System, a patient-worn biosensor that records electrocardiography (ECG) data over extended periods, facilitating accurate cardiac monitoring. G Medical Innovations also develops a Wireless Vital Signs Monitoring System, which provides continuous, real-time monitoring of vital signs and biometrics. These solutions cater to both independent diagnostic testing facilities and individual patients seeking private monitoring services. In addition to its device offerings, G Medical Innovations provides various accessories to support its healthcare products, ensuring a comprehensive and integrated user experience. The company's focus on mobile health and telemedicine positions it to capitalize on the growing demand for remote patient monitoring and personalized healthcare solutions.
What Products and Services Does GMVDF Offer?
- Develops the Prizma, a multi-sensor device for vital signs monitoring and health trend reporting.
- Offers the Extended Holter Patch System, a wearable biosensor for capturing electrocardiography (ECG) data.
- Creates Wireless Vital Signs Monitoring Systems for continuous, real-time biometric monitoring.
- Provides independent diagnostic testing facility monitoring services.
- Offers private monitoring services for individual patients.
- Supplies accessories for its healthcare products.
How Does GMVDF Make Money?
- Sells medical devices like the Prizma and Extended Holter Patch System.
- Generates revenue through monitoring services for diagnostic facilities.
- Offers private monitoring services directly to patients.
- Sells accessories related to its medical devices.
What Industry Does GMVDF Operate In?
G Medical Innovations Holdings Ltd operates within the expanding medical devices industry, specifically targeting the mobile health and telemedicine segments. The industry is characterized by increasing demand for remote patient monitoring, driven by factors such as an aging population, rising healthcare costs, and advancements in wireless technology. The competitive landscape includes established medical device manufacturers and emerging telehealth companies. G Medical Innovations aims to differentiate itself through its integrated solutions for vital signs monitoring and ECG data capture, catering to both healthcare providers and individual patients. The global telemedicine market is projected to reach $400 billion by 2027, reflecting substantial growth potential.
Who Are GMVDF's Key Customers?
- Independent diagnostic testing facilities utilizing monitoring services.
- Individual patients seeking private health monitoring solutions.
- Healthcare providers integrating devices into their practice.
- Telehealth platforms incorporating devices into their offerings.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
G Medical Innovations Holdings Ltd operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Rehovot, IL. The company is led by CEO Yacov Geva. GMVDF has traded publicly since 2021.
Key Financial Metrics
Return on equity for G Medical Innovations Holdings Ltd stands at 368.0%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.22 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
G Medical Innovations Holdings Ltd's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
GMVDF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
GMVDF Latest News
No recent news available for GMVDF.
GMVDF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GMVDF.
Price Targets
Wall Street price target analysis for GMVDF.
GMVDF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GMVDF; grades run from A+ (80-100) to F (below 30).
GMVDF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that G Medical Innovations Holdings Ltd may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ due to the potential for less stringent regulatory oversight and reporting requirements.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Less stringent regulatory oversight.
- Potential for delisting or trading suspensions.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Company has been in operation since 2014.
- Focus on developing innovative medical devices.
- Presence in the mobile health and telemedicine market.
- Development of proprietary technology (Prizma).
Common Questions About GMVDF (Healthcare)
What do analysts say about GMVDF stock?
Currently, formal analyst coverage of G Medical Innovations Holdings Ltd (GMVDF) is limited, likely due to its OTC listing and small market capitalization. Key valuation metrics are difficult to assess given the company's negative free cash flow and early commercial stage.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing and early commercial stage.
- Analyst coverage is minimal, making independent assessment crucial.